What Is The Leading Driver Behind Surge In Infectious Diseases Fueling The Growth Of The Market Due To Rising Pathogen Transmission And Research Demand Market Expansion in 2025

Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Will the Organoid Kit Industry Market Size Be by 2025?
In recent times, the organoid kit market has experienced swift expansion. Its value is projected to increase from $1.13 billion in 2024 to $1.31 billion in 2025, showing a compound annual growth rate (CAGR) of 16.4%. Reasons for this robust growth during the historic period include the surge in stem cell biology research, the expanding use of organoids in both drug toxicity testing and cancer research, the rising availability of special cell culture media, and the growing prominence of animal-free testing models.

What's the Long-Term Growth Forecast for the Organoid Kit Market Size Through 2029?
In the forthcoming years, the organoid kit market is predicted to experience rapid expansion, with a projected value of $2.37 billion in 2029 and a compound annual growth rate (CAGR) of 16.0%. This growth within the predicted timeframe can be tied to factors such as the integration of artificial intelligence (AI) and automation, the increased usage of organoids for gene editing purposes, advancements in the creation of personalized organoid kits, increased funding for cutting-edge 3D bioprinting technologies, and the rising use of organoids in rare disease modelling. Some significant trends projected during this period include the progression in organ-on-a-chip technology, the application of AI for personalized medicine, developments in 3D cell culture systems, enlargement of organoid-based drug discovery platforms, and the cooperative efforts of biotech companies and academic institutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/organoid-kit-global-market-report

What Are the Key Growth Drivers Fueling the Organoid Kit Market Expansion?
The growth of the organoid kit market is forecasted to be driven by the rising occurrences of infectious diseases. Infectious diseases are illnesses resulting from harmful microorganisms like bacteria, viruses, fungi, or parasites that can spread directly or indirectly amongst individuals. The prevalence of such diseases is fueled by unhygienic conditions and overcrowding, leading to the expedited transmission of pathogens and elevated infection rates. Through the use of organoid kits, researchers can effectively eliminate infectious diseases by creating models of human tissues in labs. This allows for the highly accurate study of various facets of pathogens such as their behavior, mechanisms of infection, and potential treatments. For example, in 2025, the UK Health Security Agency (UKHSA) reported that tuberculosis (TB) continues to pose a substantial public health problem in England. Furthermore, the most recent data revealed an 11% rise in identified cases of TB, with nearly 500 more cases reported, escalating from 4,380 in 2022 to 4,855 in 2023. Hence, the escalating prevalence of infectious diseases acts as a catalyst for the expansion of the organoid kit market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28286&type=smp

What Are the Key Trends Driving Organoid Kit Market Growth?
Leading corporations in the organoid kit sector have been strategizing on creating rapid aggregate formations as a method to hasten organoid development timelines, enhance consistency, and provide high-throughput applications for drug discovery, disease replicating, and personalized healthcare. A quick aggregate formation refers to the potential to instantly produce thousands of standard pluripotent stem cell aggregates within a day, thus reducing the duration required for organoid development significantly. For instance, Pluristyx Inc., a biotech firm located in the US, introduced its PluriForm Organoid Kit in June 2025. The kit, which is designed to streamline the production of pluripotent stem cell clusters and expedite organoid growth, provides a ready-to-use platform that truncates the timeline required for creating mature organoids from a period of months to mere weeks. This involves an amalgamation of optimized growth mediums and standardized procedures that warrant consistent outcomes across a plethora of cell types. It also caters to high-throughput applications making it apt for large-scale disease modeling and drug assessment.

How Is the Organoid Kit Market Segmented?
The organoid kit market covered in this report is segmented as

1) By Type, Brain Organoids, Kidney Organoids, Intestinal Organoids, Liver Organoids, Other Organoid Types
2) By Technology, 3D Cell Culture Technology, Microfluidics Technology, Bioprinting Technology, Electrospinning Technology
3) By Source, Human-Derived Organoids, Animal-Derived Organoids, Cell Line-Derived Organoids
4) By Application, Drug Discovery and Development, Disease Modeling, Personalized Medicine, Regenerative Medicine, Other Applications
5) By End-User, Research Institutes, Pharmaceutical Companies, Contract Research Organizations, Biotech Companies

Subsegments:
1) By Brain Organoids, Cerebral Organoids, Midbrain Organoids, Retinal Organoids
2) By Kidney Organoids, Nephron Organoids, Collecting Duct Organoids, Glomerular Organoids
3) By Intestinal Organoids, Small Intestine Organoids, Colon Organoids, Gastric Organoids
4) By Liver Organoids, Hepatic Organoids, Cholangiocyte Organoids, Biliary Organoids
5) By Other Organoid Types, Pancreatic Organoids, Lung Organoids, Heart Organoids, Tumor Organoids

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=28286&type=smp

Which Companies Are Leading the Charge in Organoid Kit Market Innovation?
Major companies operating in the organoid kit market are Thermo Fisher Scientific Inc., bioGenous Inc., Bio-Techne Corporation, STEMCELL Technologies Inc., Molecular Devices LLC, Takara Bio Inc., American Type Culture Collection (ATCC), ACROBiosystems Inc., Crown Bioscience International, Creative Biolabs Inc., Emulate Inc., CN Bio Innovations Limited, Novoprotein Scientific Inc., MedChemExpress LLC, Xylyx Bio Inc., MIMETAS B.V., Prellis Biologics Inc., TheWell Bioscience Inc., InSCREENeX GmbH, AMS Biotechnology (Europe) Limited (AMSBIO).

Which Regions Are Leading the Global Organoid Kit Market in Revenue?
North America was the largest region in the organoid kit market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in organoid kit report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=28286

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Saumya Sahey
Europe: +44 7882 955267,
Asia: +44 7882 955267 & +91 8897263534,
Americas: +1 310-496-7795
Email: saumyas@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.